Canada markets open in 1 hour 55 minutes

  • S&P/TSX

    18,421.60
    +121.98 (+0.67%)
     

  • S&P 500

    3,870.29
    -31.53 (-0.81%)
     

  • DOW

    31,391.52
    -143.99 (-0.46%)
     

  • CAD/USD

    0.7921
    +0.0009 (+0.12%)
     

  • CRUDE OIL

    60.69
    +0.94 (+1.57%)
     

  • BTC-CAD

    65,218.75
    +3,150.44 (+5.08%)
     

  • CMC Crypto 200

    1,032.96
    +44.86 (+4.54%)
     

  • GOLD FUTURES

    1,722.90
    -10.70 (-0.62%)
     

  • RUSSELL 2000

    2,231.51
    -43.81 (-1.93%)
     

  • 10-Yr Bond

    1.4150
    0.0000 (0.00%)
     

  • NASDAQ futures

    13,130.75
    +75.50 (+0.58%)
     

  • VOLATILITY

    22.96
    -0.39 (-1.67%)
     

  • FTSE

    6,666.17
    +52.42 (+0.79%)
     

  • NIKKEI 225

    29,559.10
    +150.93 (+0.51%)
     

  • CAD/EUR

    0.6563
    +0.0018 (+0.28%)
     

Wesley Matthews with a 2-pointer vs the Chicago Bulls

Wesley Matthews (Los Angeles Lakers) with a 2-pointer vs the Chicago Bulls, 01/23/2021

Latest Stories

  • This nightdress is so stylish you'll want to wear it out

    It also comes in a two-piece set.

  • ECB Said to See No Need for Drastic Action to Rein In Yields

    (Bloomberg) -- European Central Bank policy makers see no need for drastic action to combat rising bond yields, believing the risk to the economy is manageable with verbal interventions and the flexibility of their asset-purchase program, according to officials familiar with internal discussions.While multiple Governing Council members have spoken out to say that higher yields may be unwarranted and could undermine the euro zone as it struggles with extended pandemic lockdowns, there is no sense of panic, the officials said.A step such as expanding the overall size of their 1.85 trillion-euro ($2.24 trillion) emergency bond-buying program is currently unnecessary, they said. They didn’t say whether the pace of purchases has been stepped up in recent days, using the much-touted flexibility of the tool.One official noted that yields fell on Monday after some policy makers said the ECB would react against unwarranted increases.An ECB spokesman declined to comment.“We should keep a close eye on developments and analyze the reasons. We are of course capable of flexibly adjusting the volume of PEPP implementation at any moment,” Bundesbank President Jens Weidmann said on Wednesday at a press conference, when asked about rising yields. “But in my view there has been no radical deterioration of financing conditions.”Bank of Spain Governor Pablo Hernandez de Cos said at a separate event that rising yields may reflect market expectations of an earlier start to unwinding monetary stimulus, and that “avoiding premature increases in nominal interest rates” is essential.German bonds fell on Wednesday, led by the longest-dated debt, pushing 10-year yields up as much as four basis points to minus 0.31%, before drawing back. The euro climbed 0.1%, before reversing gains to trade 0.2% lower at $1.2063.Executive Board member Fabio Panetta addressed the topic on Tuesday, saying the jump in government-bond yields “is unwelcome and must be resisted.” He also said it is “not too late” to act.A day earlier, French Governing Council member Francois Villeroy de Galhau said that the ECB “can and must react” to any unwarranted moves threatening to undermine the economy. Vice President Luis de Guindos argued that it’s important to understand why bond yields have risen, and said officials “have the flexibility that is needed in order to react.”More policy makers are scheduled to speak on Wednesday, including Bank of Spain Governor Pablo Hernandez de Cos as well as Guindos.Yields on euro-area debt have risen since mid-February, when expectations for reflation kicked a global bond selloff into high gear. Greek and Italian 10-year yields led the charge, climbing about 20 basis points in the past two weeks.Core European debt was also ensnared, with benchmark German yields climbing to levels last seen in March 2020 and French yields turning positive for the first time since June.Higher government bond yields pose a problem for the euro area because they are used by banks as a reference point for lending. The region’s recovery is already expected to be slower than that of many other advanced economies, in part due to its slow vaccine roll-out, and higher borrowing costs could further damp momentum.Yields are being pushed up by a global sell-off of longer-term government bonds originating in the U.S. where prospects of another dose of massive fiscal stimulus are bolstering the economy.Fire FightingFigures published this week surprised investors by showing that the central bank actually slowed purchasing last week, despite President Christine Lagarde saying policy makers are “closely monitoring” the rise in nominal bond yields.Those figures don’t reflect orders made Thursday and Friday, as transactions take a couple of days to settle and show up in the central bank’s accounts. This week’s purchasing data will be published next Monday and Tuesday.Investors have been closely watching for any signs of market intervention by the ECB. Vincent Juvyns, a strategist at JPMorgan Asset Management, said on Bloomberg radio that in contrast to the U.S., where the economy is being boosted by massive stimulus, “it is probably too early to allow rates to rise in Europe.”“I would hope and expect that the ECB would be a bit fire-fighting with additional buying in the coming weeks and months,” he said.(Updates with comment from De Cos in seventh paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • GLOBAL MARKETS-World stocks gain as bond yields steady

    Shares from Asia to Europe gained on Wednesday, as a retreat in U.S. Treasury yields fuelled demand for riskier assets from oil to bitcoin and kept the dollar pinned down. The Euro STOXX 600 added 0.5%, with Frankfurt shares climbing 1% to a record high and London's FTSE gaining 1.1% before the UK's new budget is introduced, with measures to boost the economy. Euro zone government bond yields were little changed, with the benchmark German 10-year Bund yield flat at -0.34%.

  • Budget live: Chancellor sets out his spending plans

    Rishi Sunak has pledged to do ‘whatever it takes’ to help people and businesses through the coronavirus crisis.

  • Laurentian Bank Financial Group declares dividends on its common shares

    MONTREAL, March 03, 2021 (GLOBE NEWSWIRE) -- At its meeting held on March 2, 2021, the Board of Directors of the Laurentian Bank of Canada (TSX: LB) (the “Bank”) declared a regular quarterly dividend of 40 cents per share on the common shares payable on May 1, 2021 to the holders of record at the close of business on April 1, 2021. The above-mentioned dividends are designated as eligible dividends for the purposes of the Income Tax Act (Canada) and any similar provincial and territorial legislation. The above-mentioned shares are eligible shares under the Bank’s Shareholder Dividend Reinvestment and Share Purchase Plan (the “Plan”). Consequently, the holders of such shares may elect to reinvest their dividends in newly issued common shares of the Bank. Such purchases will be made at the applicable investment price as defined in the Plan, less a discount of 2%, and no brokerage commissions or service charges of any kind will apply. In addition, holders of such shares are entitled to make monthly optional cash payments to purchase additional common shares in accordance with the terms of the Plan. For more information, please contact Computershare Trust Company of Canada at 1-800-564-6253. Beneficial or non-registered owners of common and preferred shares must contact their financial institution or broker for instructions on how to participate in the Plan. About Laurentian Bank Financial Group Founded in 1846, Laurentian Bank Financial Group is a diversified financial services provider whose mission is to help its customers improve their financial health. The Laurentian Bank of Canada and its entities are collectively referred to as Laurentian Bank Financial Group (the “Group” or the “Bank”). With more than 2,900 employees guided by the values of proximity, simplicity and honesty, the Group provides a broad range of advice-based solutions and services to its personal, business and institutional customers. With pan-Canadian activities and a presence in the U.S., the Group is an important player in numerous market segments. The Group has $45.2 billion in balance sheet assets and $29.2 billion in assets under administration. Information: Fabrice TremblayAdvisor, CommunicationsOffice: 514 284-4500, extension 40020Mobile: 438 989-6070fabrice.tremblay@lbcfg.ca

  • UK contactless payment limit to rise to £100

    UK contactless payment limit to rise to £100Move, to be announced by Rishi Sunak in the budget, may not be rolled out until later this year The limit on tap-and-go card spending was increased to £45 last year as retailers sought ways to cut the need for physical contact in shops amid the Covid pandemic. Photograph: Bloomberg via Getty Images

  • SoftBank aims to double PayPay users in cashless payments fight

    SoftBank aims to double user numbers at its PayPay QR code payment app in the next three to four years, an executive at its domestic internet subsidiary Z Holdings told Reuters on Wednesday, as it seeks to extend its lead in cashless payments. PayPay has used SoftBank's sales network and aggressive rebates to attract 36 million users in the three years since launch, driving a shift to push Japanese consumers to digital payments away from their traditional preference for cash. "We want to double the user base during the investment phase," Z Holdings co-CEO Kentaro Kawabe said in a joint interview with fellow co-CEO Takeshi Idezawa.

  • Serie A: Abandoned match between Juventus, Napoli rescheduled for 17 March

    Napoli failed to turn up to the 4 October fixture after being ordered not to travel by local health authorities following two cases of COVID-19 in their team.

  • Cyprus to lift veil of secrecy with register of company owners

    Cyprus plans to launch a register in coming months identifying the owners of thousands of companies on the island, lifting a veil of secrecy on opaque and complex corporate structures that campaigners say can help criminals seeking to hide their loot. Details of thousands of companies domiciled on the island, many thought to have Russian links, will be collected from March 16 to be entered in a so-called Ultimate Beneficial Owner (UBO) register. Supporters say the register, a requirement of European Union anti-money laundering (AML) regulations, could be a game changer for Cyprus, which activists say has in the past been a magnet for those concealing wealth behind brass plate companies, lured by competitive tax rates.

  • Tanger Outlets Is Showing Resilience in Brick-and-Mortar Retail's New Normal

    With the pandemic keeping shoppers away from brick-and-mortar retailers and especially malls, Tanger Factory Outlet Centers (NYSE: SKT) posted some surprising numbers in its most recent quarter. On this Motley Fool Live episode, recorded on Feb. 18, Fool contributor Matt Frankel dives into the business of this popular outdoor outlet mall to see what's behind its resilient performance. Matt Frankel: The Brians, we haven't heard from Brian Feroldi yet, but I'd assume the two companies that they are talking about are firing on all cylinders lately.

  • Northern Trust Selected by Osmosis Investment Management to Support Fossil Fuel Free Common Contractual Fund

    Northern Trust today announced it has been selected by Osmosis Investment Management (Osmosis) to provide fund administration, global custody and depositary services for the Osmosis Resource Efficient Core Equity (ex-fossil fuels) Fund in a Collective Investment in Transferable Securities (UCITS) Common Contractual Fund (CCF).

  • OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021

    ROCHESTER, Mich., March 03, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the 33rd Annual ROTH Growth Conference being held virtually on March 15-17, 2021. The conference will feature presentations from public and private companies across a variety of industry sectors, followed by one-on-one and small group meetings, as well as expert panels and fireside chats. Past events have featured more than 550 participating companies and drawn more than 5,000 attendees that include institutional investors, analysts, family offices and high-net-worth investors. OptimizeRx pre-recorded video webcast presentation is available today here and via the investor relations section of the company’s website at www.optimizerx.com. OptimizeRx CEO, Will Febbo, will participate in one-on-one meetings with investors and analysts during the conference. He plans to discuss the company’s recently reported record 2020 results, with a 76% increase in revenue to $43.3 million largely driven by what is seen as a permanent shift to more digital enablement. The company also finished the year with a sales pipeline of more than $180 million, including enterprise deals valued at more than $50 million. To submit a registration request, click here. To schedule a one-on-one meeting with OptimizeRx, please contact your ROTH representative. For any questions about the company, contact Ron Both of CMA at (949) 432-7557 or submit your request here. About ROTH Capital PartnersROTH Capital Partners, LLC “ROTH” is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately held and employee owned. For more information on ROTH, please visit www.roth.com. About OptimizeRxOptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement. For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com. Important Cautions Regarding Forward-Looking Statements This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks. OptimizeRx ContactDoug Baker, CFOTel (248) 651-6568 x807dbaker@optimizerx.com Media Relations ContactMaira Alejandra, Media Relations ManagerTel (754) 245-7070malejandra@optimizerx.com Investor Relations ContactRon Both, CMATel (949) 432-7557Email Contact

  • Report: Egypt's Aboul Gheit reappointed Arab League chief

    Arab foreign ministers on Wednesday reappointed veteran Egyptian diplomat as the secretary general of the Cairo-based Arab League, Egypt’s state-run news agency reported. Ahmed Aboul Gheit, a former ambassador to the United Nations and Egypt’s last foreign minister under ousted president Hosni Mubarak, won the backing of the Arab foreign ministers meeting in Cairo, MENA's report said. In January, Egypt’s President Abdel Fattah el-Sissi announced that Cairo would nominate Aboul Gheit for a second, five-year term as the chief of the 22-member bloc.

  • Biden Announces Johnson & Johnson, Merck COVID Vaccine Collaboration in Wartime Effort

    President Biden announced the "type of collaboration between companies we saw in World War Two," with two competitors working together. Merck will help Johnson & Johnson produce its COVID vaccine,...

  • This Mini Foldable Trampoline Makes At-Home Cardio Fun — and It’s Nearly 50% Off

    Literally add some pep to your step

  • Susan Collins Will Vote For Interior Secretary Nominee Deb Haaland

    The Maine senator is the first Republican to support Biden's historic pick to lead the federal agency with oversight of public lands and tribal obligations.

  • SunOpta Announces Fourth Quarter Fiscal 2020 Financial Results

    SunOpta Inc. ("SunOpta" or the "Company") (Nasdaq:STKL) (TSX:SOY), a leading healthy food and beverage company focused on plant-based foods and beverages and fruit-based foods and beverages, today announced financial results for the fourth quarter ended January 2, 2021.

  • Hair Transplant Market Size & Trends Value Will Reach USD 25,116.67 Million By 2026: Facts & Factors

    According to the [190+ Pages] research study; the global Hair Transplant Market in 2019 was approximately USD 5,612.89 Million. The market is expected to grow at a CAGR of 22.1% and is anticipated to reach around USD 25,116.67 Million by 2026. Top market players are Bosley, Restoration Robotics Inc., MEDICAMAT, Cole Instruments Inc. and others.New York, NY, March 03, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Hair Transplant Market By Surgery Method (Single Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE) and Others), By Surgical Type (Headhair Transplant, Eyebrow Transplant, Frontal Hairline Lowering or Reconstruction and Others) By distribution channel (Hospital, Tricology Clinics, Dermatological Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026”. “According to the research study, the global Hair Transplant Market was estimated at USD 5,612.89 Million in 2019 and is expected to reach USD 25,116.67 Million by 2026. The global Hair Transplant Market is expected to grow at a compound annual growth rate (CAGR) of 22.1% from 2019 to 2026”. A hair transplant is a kind of surgical technique that involved the removal of hair follicles from one part of the body to the affected part of the body. The site where hairs get removed called donor sites and the place where this hair is used called recipient sites. Due to the beneficial effect of hair transplantation compared to other methods, these methods not only prefers for people suffering from hair loss but also for those who want to alter their hairlines or acquire an attractive look. Donor sites can be any part of the body like, Face, Legs, Head, and others. Request Your Free Sample Report of Hair Transplant Market @ https://www.fnfresearch.com/sample/hair-transplant-market-by-surgery-method-single-follicular-949 (The free sample of this report is readily available on request). Our Free Sample Report Includes: 2020 Updated Report Introduction, Overview, and In-depth industry analysisCOVID-19 Pandemic Outbreak Impact Analysis Included190+ Pages Research Report (Inclusion of Updated Research)Provide Chapter-wise guidance on Request2020 Updated Regional Analysis with Graphical Representation of Size, Share & TrendsIncludes Updated List of table & figuresUpdated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue AnalysisFacts and Factors research methodology (Note: The sample of this report is updated with COVID-19 impact analysis before delivery) Key Questions Answered in this Report 1) What was the impact of COVID-19 on the Hair Transplant Market? 2) What is the market size, share of the Hair Transplant Market? 3) Who are the top market players in Hair Transplant Market? 4) What will be the future market of the Hair Transplant Market? Key Offerings: Market Size & Forecast by Revenue | 2020−2026Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunitiesMarket Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geographyCompetitive Landscape – Top key vendors and other prominent vendors Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/hair-transplant-market-by-surgery-method-single-follicular-949 (You may enquire a report quote OR available discount offers to our sales team before purchase.) Impact Analysis of COVID-19 Pandemic on Businesses: Know Short Term and Long Term Impact Most of the businesses are facing a growing litany of business-critical concerns related to the coronavirus outbreak, including supply chain disruptions, a risk of a recession, and a potential drop in consumer spending. All these scenarios will play out differently across various regions and industries, making accurate and timely market research more essential than ever. We at Facts and Factors (http://www.fnfresearch.com) understand how difficult it is for you to plan, strategize, or make business decisions, and as such, we have your back to support you in these uncertain times with our research insights. Our team of consultants, analysts, and experts has developed an analytical model tool for markets that helps us to assess the impact of the virus more effectively on the industrial markets. We are further implementing these insights into our reports for a better understanding of our clients. Request COVID-19 Impact Analysis on Businesses: https://www.fnfresearch.com/sample/hair-transplant-market-by-surgery-method-single-follicular-949 The market is driven by an increasing number of hair loss cases across the world. In addition, the rising prevalence of guided baldness among genders across the world is one of the major drivers which helps in the growth of the market. Furthermore, keen public interest followed by increasing per capita expenditures in healthcare across the world is the major driving factor for this market. The high cost of treatment and lack of facility is one of the major restraint factors affecting the growth of the market. Continuous research and development may help to create futuristic opportunities within the forecast periods. Industry Major Market Players MEDICAMAT Restoration Robotics Inc. Cole Instruments Inc. Bernstein Medical Ethics hair Instruments Bosley To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/hair-transplant-market-by-surgery-method-single-follicular-949 In product type, the market is classified into Single Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE), and others. Single Follicular Unit Transplantation (FUT) acquires the largest market share in the year 2019. This segment acquires more than half of the global hair transplant market. The growth is accounted for due to patient with hair baldness is larger in number. Follicular unit transplantation is a hair restoration technique where patients are transplanted in a group of 1 to 4 hairs in the patients. Based on surgery type, the market is in-depth fragmented into four types: Eyebrow Transplant, Head hair Transplant, Frontal Hairline Lowering or Reconstruction, and Others. The head hair Transplant segment is the largest market in the year 2019. The Head has a widely affected region. People show a keen interest in the restoration of hair in this region. Based on end-users, the market is classified into hospitals, Trico logy Clinics, Dermatological Clinics, and Others. The dermatological clinic holds the largest percentage of patients of hair transplants in the year 2019. Dermatological Clinic is an institution providing better help related to skin and skin-related disorders. These segments account for around more than 40% of market shares in the year 2019. Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/hair-transplant-market-by-surgery-method-single-follicular-949 The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Hair Transplant sector. Key strategic developments in the Hair Transplant market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Hair Transplant market are appropriately highlighted in the report. The Hair Transplant market size is estimated to develop with healthy CAGR in upcoming years. Hair Transplant has a wide application that leads to the growth of the industry. Nonetheless, lack of knowledge is likely to obstruct the market in the coming years. Request Customized Copy of Report @ https://www.fnfresearch.com/customization/hair-transplant-market-by-surgery-method-single-follicular-949 (We customize your report according to your research need. Ask our sales team for report customization.) The global Hair Transplant market has been segmented on the basis of product, end-user, and application. On the basis of product segment, the target market is segmented into Single Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE), and others. On the basis of the application segment, the global market is segmented into Headhair Transplant, Eyebrow Transplant, Frontal Hairline Lowering or Reconstruction, and Others. On the basis of end-Users, Market is classified into Hospital, Tricology Clinics, Dermatological Clinics, and Others Americas, Europe, Asia Pacific, and the MEA regions are being categorized in the report. North America is the biggest market for hair transplants. North America equipped with scientific progressions, dexterous people, and superior healthcare infrastructure is one of the major causes. The European and North American markets have a massive portion of the market. The Asia-Pacific region is probable to develop at an extensive high CAGR by 2026. Browse the full “Hair Transplant Market By Surgery Method (Single Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE) and Others), By Surgical Type (Headhair Transplant, Eyebrow Transplant, Frontal Hairline Lowering or Reconstruction and Others) By distribution channel (Hospital, Tricology Clinics, Dermatological Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026” report at https://www.fnfresearch.com/hair-transplant-market-by-surgery-method-single-follicular-949 Key Insights from Primary Research As per our primary respondents, the global hair transplant market is set to grow annually at a rate of around 21.3%.It was established through primary research that the global hair transplant market was valued at around USD 5,612.23 Billion in 2019.The “Single Follicular Unit Transplantation (FUT)” category, on the basis of product segmentation, was the leading revenue-generating category in 2019.On the basis of surgery type segmentation, the “Head Hair Transplant” category was the leading revenue-generating category in 2019.Based on the region, North America was the leading revenue-generating category in 2019. The taxonomy of the Hair Transplant Market by its scope and segmentation is as follows: Global Hair Transplant Market: Surgery Method Segment Analysis Follicular Unit Transplantation (FUT)Follicular Unit Extraction (FUE)Others Global Hair Transplant Market: Surgery Type Segment Analysis Head hair TransplantEyebrow TransplantFrontal Hairline Lowering or ReconstructionOthers Global Hair Transplant Market: End-Users Segment Analysis HospitalTricology ClinicsDermatological ClinicsOthers Related Reports: Plasma Therapy Market: https://www.fnfresearch.com/plasma-therapy-market-type-pure-prp-leucocyte-rich-1279 Pneumonia Therapeutics Market: https://www.fnfresearch.com/pneumonia-therapeutics-market-by-product-type-drugs-branded Antibody Drug Conjugates Market: https://www.fnfresearch.com/antibody-drug-conjugates-market-by-drugs-adcetris-and Tissue Culture Reagents Market: https://www.fnfresearch.com/tissue-culture-reagents-market-by-product-40-70m-1253 Prebiotics Ingredients Market: https://www.fnfresearch.com/prebiotics-ingredients-market-by-application-food-beverages-agricultural-1231 About Facts & Factors (FnF Research): Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business. Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch Follow Us Twitter: https://twitter.com/fnfresearch Contact Us: Facts & Factors USA: +1-347-989-3985 Email: sales@fnfresearch.com Web: https://www.fnfresearch.com Blog: http://fnfnewsblog.com

  • Daktronics, Inc. Announces Third Quarter Fiscal 2021 Results

    BROOKINGS, S.D., March 03, 2021 (GLOBE NEWSWIRE) -- Daktronics, Inc. (NASDAQ - DAKT) today reported fiscal 2021 third quarter results. Daktronics reported fiscal 2021 third quarter net sales of $94.1 million, operating loss of $0.2 million, net loss of $0.2 million, and earnings per diluted share of $0.00. This compares to net sales of $127.7 million, operating loss of $9.2 million, net loss of $12.7 million, and $0.28 per diluted share, for the third quarter of fiscal 2020. Fiscal 2021 third quarter orders were $86.9 million, compared to $135.0 million for the third quarter of fiscal 2020. Product order backlog at the end of the fiscal 2021 third quarter was $195 million, compared to $187 million a year earlier and $201 million at the end of the second quarter of fiscal 2021.(1) For the nine months ended January 30, 2021, net sales were $365.2 million, operating income was $16.0 million, net income was $10.7 million, and earnings per diluted share was $0.24 per diluted share. This compares to net sales of $482.8 million, operating income of $3.3 million, net income of $1.6 million, and $0.03 per diluted share for the same period in fiscal 2020. Fiscal 2021 is a 52-week year and fiscal 2020 was a 53-week year; therefore, the nine months ended January 30, 2021 contains operating results for 39 weeks while the nine months ended February 1, 2020 contained operating results for 40 weeks. Sales, orders, and other results of operations were impacted due to the additional week of operations. Cash generated by operating activities in the first nine months of fiscal 2021 was $48.2 million, compared to cash generated of $6.2 million in the first nine months of fiscal 2020. Cash generated by operating activities is primarily derived from cash received from customers, offset by cash payments for inventories, subcontractors, employee related costs, and operating expense outflows. Year-to-date cash provided from operations differed as compared to last year primarily due to a focus on customer collections, decreasing inventory levels, lowering personnel and operating expense outflows as we manage operations through the uncertain COVID times. Cash generation and use can vary based on order timing and levels, varying contractual payment terms from customers, and payments for inventory to meet delivery and installation schedules. Free cash flow, defined as cash provided by or used in operating activities less net investment in property and equipment, was a positive $41.8 million for the first nine months of fiscal 2021, as compared to a negative $7.2 million for the same period of fiscal 2020. Net investment in property and equipment was $6.5 million for the first nine months of fiscal 2021, as compared to $13.4 million for the first nine months of fiscal 2020. Cash, restricted cash, and marketable securities at the end of the third quarter of fiscal 2021 were $81.0 million, which compares to $42.1 million at the end of the third quarter of fiscal 2020 and $41.6 million at the end of fiscal 2020. Borrowings on the line of credit were $15.0 million at the end of the third quarter of fiscal 2021 up from $0 at the end of the third quarter of fiscal 2020 and consistent with the $15.0 million at the end of fiscal 2020. Orders for the third quarter of fiscal 2021 decreased 35.6 percent as compared to the third quarter of fiscal 2020. Orders for the nine months ended January 30, 2021 decreased 27.2 percent as compared to the same period one year ago. Each business unit's order volume was lower in fiscal 2021 due to lower market activity from the resulting economic and business impacts of the COVID-19 pandemic and related timing of large contract orders. Net sales decreased by 26.3 percent in the third quarter of fiscal 2021 as compared to the third quarter of fiscal 2020. Net sales for the nine months ended January 30, 2021 decreased 24.4 percent as compared to the same period one year ago. Net sales decreased in all business units for the same reasons causing order booking declines and due to varied timing in the related conversion to sales based on customer project schedules. Gross profit as a percentage of net sales was 25.4 percent for the third quarter of fiscal 2021 as compared to 19.2 percent a year earlier. The improved gross profit rate in the third quarter of fiscal 2021 is a result of the mix of service agreement and product sales and a $2.1 million litigation claim reversal. In comparison, during the third quarter of fiscal 2020, we experienced adverse impacts of a project with cost overruns and tariff related expenses. Operating expenses for the third quarter of fiscal 2021 were $24.2 million, compared to $33.6 million for the third quarter of fiscal 2020, or a decrease of 28.0 percent. This decline is attributed to our focus on managing our expenses to expected order volumes. Declines in overall operating expenses were attributed to lower personnel related costs, reduced third-party contractor use, lower travel and entertainment activities, and lowered marketing and convention events offset by an increase in bad debt expense. Operating loss as a percent of sales for the quarter was 0.3 percent as compared to an operating loss as a percent of sales of 7.2 percent during the third quarter of fiscal 2020. The effective tax rate expense for the third quarter of fiscal 2021 was 82.0 percent compared to an effective tax rate benefit of 37.9 percent for the third quarter of fiscal 2020. Our fiscal 2021 year-to-date effective rate expense was 21.3 percent compared to fiscal 2020 year-to-date effective rate expense of 51.6 percent. The change in the effective tax rate year-over-year was driven primarily by a decrease in tax credits and other permanent differences as a percentage of estimated current fiscal year pre-tax income. Reece Kurtenbach, chairman, president and chief executive officer, stated, "Our third quarter orders, sales and profit levels are traditionally lighter than other quarters due to the seasonality of our sports business, construction cycles, and the reduced number of production dates due to holidays during the quarter. This year, our results have also been impacted by the pandemic. We continue to monitor the pandemic's impact on the markets we serve. Areas of our business that were impacted the most are those that serve customers in large gathering spaces which includes our sports and entertainment, mass transit, and airport markets. Our Out-of-Home advertising customers were impacted due to a reduction in national advertising spend and have chosen to delay orders. Customers using on-premise applications are less impacted and are continuing to utilize audio visual systems to inform and persuade their audiences during this time. We continue to strategically make choices on levels of capacity and investments in capital assets and development initiatives. We also continued the suspension of dividend and share repurchases to help us maintain stability in liquidity and our cash position." (1) Backlog is not a measure defined by U.S. generally accepted accounting principles ("GAAP"), and our methodology for determining backlog may vary from the methodology used by other companies in determining their backlog amounts. For more information related to backlog, see Part I, Item 1. Business of our Annual Report on Form 10-K for the fiscal year ended May 2, 2020. OutlookKurtenbach added, "Our backlog going into the fourth quarter is strong and we believe the audiovisual industry fundamentals will drive long-term growth for our business. However, the near-term outlook shows areas of contraction and greater volatility. We are focused on promoting our value to new and core markets, while managing our cost structure to meet the uncertain demand. With the COVID-19 vaccine distribution underway, we remain focused on emerging as a stronger organization and to be positioned to capitalize on the recovery from this pandemic." About DaktronicsDaktronics has strong leadership positions in, and is the world's largest supplier of, large-screen video displays, electronic scoreboards, LED text and graphics displays, and related control systems. The company excels in the control of display systems, including those that require integration of multiple complex displays showing real-time information, graphics, animation, and video. Daktronics designs, manufactures, markets and services display systems for customers around the world in four domestic business units: Live Events, Commercial, High School Park and Recreation, and Transportation, and one International business unit. For more information, visit the company's website at: www.daktronics.com, email the company at investor@daktronics.com, call (605) 692-0200 or toll-free (800) 843-5843 in the United States, or write to the company at 201 Daktronics Dr., P.O. Box 5128, Brookings, S.D. 57006-5128. Safe Harbor StatementCautionary Notice: In addition to statements of historical fact, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and is intended to enjoy the protection of that Act. These forward-looking statements reflect the Company's expectations or beliefs concerning future events. The Company cautions that these and similar statements involve risk and uncertainties which could cause actual results to differ materially from our expectations, including, but not limited to, changes in economic and market conditions, management of growth, timing and magnitude of future contracts and orders, fluctuations in margins, the introduction of new products and technology, the impact of adverse weather conditions, increased regulation and other risks described in the company's SEC filings, including its Annual Report on Form 10-K for its 2020 fiscal year. Forward-looking statements are made in the context of information available as of the date stated. The Company undertakes no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur. For more information contact:INVESTOR RELATIONS:Sheila M. Anderson, Chief Financial OfficerTel (605) 692-0200Investor@daktronics.com Daktronics, Inc. and SubsidiariesConsolidated Statements of Operations(in thousands, except per share amounts)(unaudited) Three Months Ended Nine Months Ended January 30, February 1, January 30, February 1, 2021 2020 2021 2020 Net sales $94,139 $127,657 $365,150 $482,824 Cost of sales 70,198 103,175 272,134 372,750 Gross profit 23,941 24,482 93,016 110,074 Operating expenses: Selling 12,004 16,552 36,214 51,026 General and administrative 6,389 8,640 20,777 26,698 Product design and development 5,784 8,442 20,053 29,063 24,177 33,634 77,044 106,787 Operating (loss) income (236) (9,152) 15,972 3,287 Nonoperating (expense) income: Interest income 52 233 203 664 Interest expense (92) 13 (249) (53)Other (expense) income, net (913) (331) (2,377) (652) (Loss) income before income taxes (1,189) (9,237) 13,549 3,246 Income tax expense (benefit) (975) 3,497 2,880 1,676 Net (loss) income $(214) $(12,734) $10,669 $1,570 Weighted average shares outstanding: Basic 45,064 45,189 44,908 45,139 Diluted 45,064 45,189 45,061 45,412 (Loss) earnings per share: Basic $0.00 $(0.28) $0.24 $0.03 Diluted $0.00 $(0.28) $0.24 $0.03 Cash dividends declared per share $— $0.05 $— $0.15 Daktronics, Inc. and SubsidiariesConsolidated Balance Sheets(in thousands) January 30, May 2, 2021 2020 (unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents $76,877 $40,398 Restricted cash 3,884 14 Marketable securities 248 1,230 Accounts receivable, net 63,212 72,577 Inventories 72,312 86,803 Contract assets 30,310 35,467 Current maturities of long-term receivables 1,736 3,519 Prepaid expenses and other current assets 7,554 9,629 Income tax receivables 87 548 Property and equipment and other assets available for sale 2,020 1,817 Total current assets 258,240 252,002 Property and equipment, net 61,805 67,484 Long-term receivables, less current maturities 754 1,114 Goodwill 8,262 7,743 Intangibles, net 2,396 3,354 Investment in affiliates and other assets 23,608 27,683 Deferred income taxes 13,382 13,271 Total non-current assets 110,207 120,649 TOTAL ASSETS $368,447 $372,651 Daktronics, Inc. and SubsidiariesConsolidated Balance Sheets (continued)(in thousands) January 30, May 2, 2021 2020 (unaudited) LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $32,692 $47,834 Contract liabilities 53,292 50,897 Accrued expenses 26,664 36,626 Warranty obligations 10,766 9,764 Income taxes payable 2,079 844 Total current liabilities 125,493 145,965 Long-term warranty obligations 15,696 15,860 Long-term contract liabilities 10,587 10,707 Other long-term obligations 23,059 22,105 Long-term income taxes payable 554 582 Deferred income taxes 490 452 Total long-term liabilities 50,386 49,706 TOTAL LIABILITIES 175,879 195,671 SHAREHOLDERS' EQUITY: Common stock 60,575 60,010 Additional paid-in capital 46,091 44,627 Retained earnings 95,759 85,090 Treasury stock, at cost (7,297) (7,470)Accumulated other comprehensive loss (2,560) (5,277)TOTAL SHAREHOLDERS' EQUITY 192,568 176,980 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $368,447 $372,651 Daktronics, Inc. and SubsidiariesConsolidated Statements of Cash Flows(in thousands)(unaudited) Nine Months Ended January 30, February 1, 2021 2020CASH FLOWS FROM OPERATING ACTIVITIES: Net income $10,669 $1,570 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 12,848 13,197 Gain on sale of property, equipment and other assets (244) (6)Share-based compensation 1,563 1,734 Equity in loss of affiliates 1,740 430 Provision for doubtful accounts 1,551 (477)Deferred income taxes, net (21) (223)Change in operating assets and liabilities 20,115 (10,035)Net cash provided by operating activities 48,221 6,190 CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment (6,935) (13,646)Proceeds from sales of property, equipment and other assets 470 244 Proceeds from sales or maturities of marketable securities 982 24,665 Purchases of and loans to equity investment (1,328) (1,229)Net cash (used in) provided by investing activities (6,811) 10,034 CASH FLOWS FROM FINANCING ACTIVITIES: Principal payments on long-term obligations (431) (2,140)Dividends paid — (6,756)Payments for common shares repurchased — (2,329)Tax payments related to RSU issuances (125) (199)Net cash used in financing activities (556) (11,424) EFFECT OF EXCHANGE RATE CHANGES ON CASH (505) (166)NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 40,349 4,634 CASH, CASH EQUIVALENTS AND RESTRICTED CASH: Beginning of period 40,412 35,742 End of period $80,761 $40,376 Daktronics, Inc. and SubsidiariesNet Sales and Orders by Business Unit(in thousands)(unaudited) Three Months Ended Nine Months Ended January 30, February 1, Dollar Percent January 30, February 1, Dollar Percent 2021 2020 Change Change 2021 2020 Change ChangeNet Sales: Commercial $30,085 $36,880 $(6,795) (18.4)% $94,947 $120,566 $(25,619) (21.2)%Live Events 23,330 40,571 (17,241) (42.5) 112,626 159,196 (46,570) (29.3)High School Park and Recreation 14,644 14,775 (131) (0.9) 71,165 75,433 (4,268) (5.7)Transportation 11,769 13,916 (2,147) (15.4) 41,590 53,264 (11,674) (21.9)International 14,311 21,515 (7,204) (33.5) 44,822 74,365 (29,543) (39.7) $94,139 $127,657 $(33,518) (26.3)% $365,150 $482,824 $(117,674) (24.4)%Orders: Commercial $34,806 $36,898 $(2,092) (5.7)% $92,929 $119,059 $(26,130) (21.9)%Live Events 11,075 41,484 (30,409) (73.3) 93,619 149,461 (55,842) (37.4)High School Park and Recreation 16,366 20,447 (4,081) (20.0) 64,582 73,852 (9,270) (12.6)Transportation 12,991 16,203 (3,212) (19.8) 37,713 55,410 (17,697) (31.9)International 11,650 19,992 (8,342) (41.7) 55,864 75,827 (19,963) (26.3) $86,888 $135,024 $(48,136) (35.6)% $344,707 $473,609 $(128,902) (27.2)% Reconciliation of Free Cash Flow*(in thousands)(unaudited) Nine Months Ended January 30, February 1, 2021 2020Net cash provided by operating activities $48,221 $6,190 Purchases of property and equipment (6,935) (13,646)Proceeds from sales of property and equipment 470 244 Free cash flow $41,756 $(7,212) *In evaluating its business, Daktronics considers and uses free cash flow as a key measure of its operating performance. The term free cash flow is not defined under U.S. generally accepted accounting principles (“GAAP”) and is not a measure of operating income, cash flows from operating activities or other GAAP figures and should not be considered alternatives to those computations. Free cash flow is intended to provide information that may be useful for investors when assessing period to period results.

  • Cyber Apps Negotiating Acquisition of Scalable Work-From-Home HR Software Solution

    Las Vegas, Nevada--(Newsfile Corp. - March 3, 2021) - Cyber Apps World Inc. (OTC Pink: CYAP) ("Cyber Apps" or the "Company") (Cyberappsworld.com), an acquirer and developer of innovative cyber technologies with the potential for disruptive scalability and eventual spin-off success, is pleased to announce that the Company is currently in late-stage negotiations with a software development firm for the acquisition of a technology solution geared toward management of remote workers with an emphasis on ...